Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

worldpharmanewsNovember 16, 2020

Tag: Medicago , GSK , COVID-19 vaccine

PharmaSources Customer Service